Medscape Medical News, June 03, 2009 FDA Safety Changes: Remicade and Doribax The FDA has approved safety labeling revisions for infliximab intravenous infusion (Remicade) and doripenem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback